Virtual Reality Compared to Nitrous Oxide for Labor Analgesia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-18

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headsets) are non-inferior to conventional therapy (nitrous oxide) for addressing maternal needs during labor who desire non-epidural pain relief.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Virtual Reality in Labor and Delivery for Reduction in Pain

NCT03437031

Labor Pain Virtual Reality Alternative Medicine

TERMINATED NA

VR Scenario for Labor Pain Control

NCT05879848

Labor Pain

COMPLETED NA

Nitrous Oxide and Neuraxial Labor Analgesia Use on Maternal Fetal Outcomes

NCT04813874

Pregnancy

WITHDRAWN

Investigating the Effect of Virtual Reality on Labour Analgesia Use

NCT04992663

Virtual Reality Labor Pain Labor Analgesia

UNKNOWN NA

Inhaled Nitrous Oxide and Labor Analgesia

NCT01738672

Labor Pain

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will use a commercially available consumer-grade virtual reality (VR) device and nitrous oxide, a standard of care therapy for laboring women desiring non-epidural analgesic, to determine satisfaction with pain relief with each therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Labor Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Comparing VR to an "active control" of nitrous oxide as a current standard of care for non-epidural analgesic in a crossover design

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Reality then Nitrous Oxide

30 minute exposure to virtual reality, 5 minute washout period, then 30 minute exposure to nitrous oxide

Group Type ACTIVE_COMPARATOR

Oculus Quest 2 Virtual Reality Device

Intervention Type DEVICE

30 min VR experience exposure for labor analgesia. VR experiences include swimming in the ocean, walking through forests, engaging in 3D puzzles, exploring virtual lands, or interacting with musical objects

Nitrous oxide

Intervention Type DRUG

30 min exposure for labor analgesia

Nitrous Oxide then Virtual Reality

30 minute exposure to nitrous oxide, 5 minute washout period, then 30 minute exposure to virtual reality

Group Type ACTIVE_COMPARATOR

Oculus Quest 2 Virtual Reality Device

Intervention Type DEVICE

30 min VR experience exposure for labor analgesia. VR experiences include swimming in the ocean, walking through forests, engaging in 3D puzzles, exploring virtual lands, or interacting with musical objects

Nitrous oxide

Intervention Type DRUG

30 min exposure for labor analgesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oculus Quest 2 Virtual Reality Device

30 min VR experience exposure for labor analgesia. VR experiences include swimming in the ocean, walking through forests, engaging in 3D puzzles, exploring virtual lands, or interacting with musical objects

Intervention Type DEVICE

Nitrous oxide

30 min exposure for labor analgesia

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton pregnancy at \>34 weeks
* Regular uterine contractions
* Pain \> 2/10
* English speaking

Exclusion Criteria

* BMI \> 40
* Preeclampsia with severe features
* Use of IV analgesics during labor
* Diabetes requiring insulin therapy
* Claustrophobia
* History of epilepsy

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes